Search clinical trials for: Study of Minocycline in Huntington's Disease

Total 497831 results

Brainvectis, a subsidiary of Asklepios BioPharmaceutical...

Active, not recruiting

A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease

Huntington Disease

France
University of Nove de Julho

Enrolling by invitation

Evaluation of Photodynamic Therapy in Pericoronitis (pdt)

Pericoronitis

Brazil
The University of Texas Health Science Center,...
Huntington's Disease Society of America

Completed

Melatonin for Huntington's Disease (HD) Gene Carriers With HD Related Sleep Disturbance - a Pilot Study

Huntington Disease

United States
University of South Florida

Completed

Minocycline in the Treatment of Angelman Syndrome

Angelman Syndrome

United States
University of Aberdeen

Enrolling by invitation

A Pilot Study of Nutritional Status in Patients With Huntington's Disease

Huntington Disease

United Kingdom
Azidus Brasil
Cellavita Pesquisa Científica Ltda

Active, not recruiting

Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients. (ADORE-EXT)

Huntington Disease

Brazil
CHDI Foundation, Inc.
Medpace, Inc.

Active, not recruiting

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD (SHIELD HD)

Huntington Disease

United States, Canada, France, Germany, United Kingdom
BioPharmX, Inc.

Completed

Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel

Acne Vulgaris

United States
Annexon, Inc.

Completed

An Open Label Study of ANX005 in Subjects With, or at Risk for, Manifest Huntington's Disease

Huntington Disease

United States
Hoffmann-La Roche

Completed

A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease

Huntingtons Disease

United Kingdom, Netherlands
Vaccinex Inc.
Huntington Study Group

Completed

A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi (SIGNAL-HD)

Huntington's Disease

United States, Canada
EIP Pharma Inc
Voisin Consulting, Inc.

Terminated

Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease

Huntington Disease

United Kingdom
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139)

Huntington's Disease

Germany, Canada, United Kingdom
Hospital Universitario de Burgos
La Caixa Foundation; Universidad Isabel I

Completed

Energy Balance in Huntington's Disease. A Multidisciplinary Study Approach for a Complex Problem (BEHD-EM) (BEHD-EM)

Huntington Disease

Spain
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Prilenia

Completed

Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease (OPEN-HART)

Huntington Disease
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Sage Therapeutics

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B

Huntington Disease

United States
Vyne Therapeutics Inc.

Completed

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Acne Vulgaris

United States, Dominican Republic
Vyne Therapeutics Inc.

Completed

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Acne Vulgaris

United States, Dominican Republic
Vyne Therapeutics Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris

Acne Vulgaris

United States
Prilenia

Completed

A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease

Health Volunteers, Huntington Disease

Germany
Hoffmann-La Roche

Completed

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

Huntington's Disease

United Kingdom, United States, Germany, Canada
Prilenia

Terminated

A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease (Open PRIDE-HD)

Huntington's Disease

United States, Australia, Austria, Canada, France, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom
Institut National de la Santé Et de la Recherche...
Ultragenyx Pharmaceutical Inc

Completed

A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease (TRIHEP3)

Huntington Disease

France, Netherlands
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.

Oropharynx Cancer

United States
Voyager Therapeutics

Withdrawn

Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's Disease

Huntington Disease
Prilenia
Huntington Study Group; European Huntington's Disease Network

Completed

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Huntington's Disease

United States, Australia, Austria, Canada, Denmark, France, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States
Vyne Therapeutics Inc.

Completed

A Study Comparing Two Topicals in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

Meibomian Gland Dysfunction | MGD-Meibomian Gland Dysfunction

United States
Vyne Therapeutics Inc.

Completed

A Pharmacokinetic Study of Minocycline in Male and Female Volunteers

Acne

Israel
Vyne Therapeutics Inc.

Completed

A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

Acne Vulgaris

United States
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States
Jody Corey-Bloom, MD, PhD
Forest Laboratories

Completed

Study of Memantine to Treat Huntington's Disease

Huntington's Disease

United States
University Hospital, Angers

Completed

Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging (COSIMH)

Huntington's Disease

France
Children's Hospital of Philadelphia
Ilera Healthcare

Terminated

Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products (Ilera)

Epilepsy | Multiple Sclerosis | Glaucoma | Cancer | Parkinson Disease | HIV/AIDS | ALS | Autism Spectrum Disorder | Sickle Cell Disease | Spasticity, Muscle | Huntington Disease | Opioid Use | Neuropathy | Terminal Illness | Inflammatory Bowel Disease (IBD) | Intractable Pain | Ptsd | Dyskinetic Syndrome

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

Lung Cancer

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod (LEGATO-HD)

Huntington's Disease

United States, Canada, Czechia, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, United Kingdom
M.D. Anderson Cancer Center
American Cancer Society, Inc.

Completed

Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients

Colorectal Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Minocycline Study in Pancreatic Cancer Patients

Pancreatic Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil

Lung Cancer

United States
University of British Columbia
Huntington Study Group; Huntington Society of Canada

Completed

A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease (MITIGATE-HD)

Huntington Disease

Canada
Weill Medical College of Cornell University
National Institutes of Health (NIH); Baxter BioScience

Terminated

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Alzheimer's Disease

United States
Ottawa Hospital Research Institute
CSL Behring; Grifols Biologicals, LLC

Completed

Ig PRx in AECOPD: Pilot Study

Chronic Obstructive Pulmonary Disease

Canada
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

Rosacea | Papulopustular Rosacea

United States
BioPharmX, Inc.

Unknown

Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea (PRISM)

Papulopustular Rosacea

United States
Cardiff University
Health and Care Research Wales; Jacque and Gloria Gossweiler Foundation

Completed

Exploring Computerised Cognitive Training for People With Huntington's Disease (CogTrainHD)

Huntington's Disease

United Kingdom
University of California, San Francisco

Completed

Kidney and Periodontal Disease Study (KAPD)

Chronic Kidney Disease | Periodontal Disease

Search clinical trials for: Study of Minocycline in Huntington's Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations